|
|
3845 Corporate Centre Drive
O 'Fallon, MO 63368 USA
phone:
636 939 5100
fax:
636 939 6885 |
| Symbol |
SURG |
| Exchange |
Nasdaq |
| Founded |
1980 |
| Employees |
250 |
|
|
www.synergeticsusa.com |
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Micro or minimally invasive products for ophthalmic and neurosurgery.
|
 |
| Management |
| Greg Scheller, President and CEO; Pamela Boone, CFO: Kurt Gampp Jr., EVP and COO; Jerry Malis, Chief Scientific Officer
|
|
|
|
|
| Keywords |
| ophthalmic surgery, ophthalmology, surgery, neurology, neurosurgery, minimally invasive, micro invasive, disposable products, neurosurgery, spine surgery, pain control, dental
|
|
|
|
|
Description |
| Synergetics USA, Inc. designs, manufactures and markets medical devices for use primarily in ophthalmic surgery and neurosurgery and for other healthcare applications. The company was formed in the September 2005 merger of Valley Forge Scientific Corp. and Synergetics, Inc. |
 |
| Products / Services |
Synergetics products are designed and manufactured to support micro or minimally invasive surgical procedures. In addition to its surgical devices and equipment, it designs and manufactures disposable and non-disposable supplies and accessories. It also manufactures and sells bipolar electrosurgical generators and other generators, based on its DualWave technology, and complementary instrumentation and disposable products for use in neurosurgery, spine surgery, pain control and in dental applications.
The company's neurosurgical products include the OMNI ultrasonic aspirator and disposables, Tru-Micro instruments, Malis bipolar equipment, Malis disposables, Malis cord tubing sets, bipolar forceps, and endoscopic instruments. It also manufactures a lesion generator designed to coagulate living human tissue for interventional pain treatment.
|
 |
| Technology / Differentiation |
| The company's Bident Bipolar Tissue Management System allows dentists to work in direct contact with metal implants, nerves, bone, and blood vessels, eliminating collateral tissue damage from current spread and heat buildup. |
 |
| Market / Customers |
Synergetics sells its products primarily to hospitals, clinics and surgeons in approximately 70 countries.
|
 |
| Strategy |
Synergetics anticipates future growth of their neurosurgical product line which includes microsurgical instruments, capital equipment and devices for use in vitreoretinal surgery and neurosurgical applications.
|
 |
|
|
|
|